Allstate Corp Acquires 4,392 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Allstate Corp increased its stake in UnitedHealth Group by 16.0%, acquiring an additional 4,392 shares, bringing its total holdings to 31,872 shares valued at approximately $16.69 million.
• UnitedHealth Group reported a quarterly earnings miss, with earnings per share of $4.08 compared to the consensus estimate of $4.45, despite a 12.9% year-over-year revenue increase.
• The company declared a quarterly dividend of $2.21 per share, representing an annualized dividend of $8.84 with a yield of 2.9%.

Allstate Corp raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 31,872 shares of the healthcare conglomerate's stock after buying an additional 4,392 shares during the quarter. UnitedHealth Group comprises 0.5% of Allstate Corp's portfolio, making the stock its 29th biggest position. Allstate Corp's holdings in UnitedHealth Group were worth $16,693,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the company. Citizens National Bank Trust Department boosted its position in shares of UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after purchasing an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH raised its stake in UnitedHealth Group by 0.3% during the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock worth $277,641,000 after buying an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $515,000. Full Sail Capital LLC lifted its holdings in shares of UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares in the last quarter. Finally, Soros Fund Management LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $39,413,000. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $303.4150 on Friday. The firm has a market capitalization of $274.79 billion, a price-to-earnings ratio of 13.15, a P/E/G ratio of 1.93 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The stock's 50 day moving average price is $288.51 and its two-hundred day moving average price is $391.21.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 EPS. The firm's quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of research analyst reports. Erste Group Bank lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Wednesday, April 30th. Raymond James Financial cut UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. HSBC restated a "reduce" rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Truist Financial lowered their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. Finally, JPMorgan Chase & Co. reduced their target price on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $365.38.

Insider Buying and Selling

In other news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.